Steven M. Eyl
Net Worth

Last updated:

What is Steven M. Eyl net worth?

The estimated net worth of Mr. Steven M. Eyl is at least $7,798,858 as of 7 Mar 2022. He has earned $2,585,458 from insider trading and has received compensation worth at least $5,213,400 in Heska Corporation.

What is the salary of Steven M. Eyl?

Mr. Steven M. Eyl salary is $521,340 per year as Executive Vice President, Chief Commercial Officer & Pres of scil animal care company in Heska Corporation.

How old is Steven M. Eyl?

Mr. Steven M. Eyl is 59 years old, born in 1966.

What stocks does Steven M. Eyl currently own?

As insider, Mr. Steven M. Eyl owns shares in one company:

Company Title Shares Price per share Total value
Heska Corporation (HSKA) Executive Vice President, Chief Commercial Officer & Pres of scil animal care company 10,048 $0 $0

What does Heska Corporation do?

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

HSKA logo
HSKA
Heska Corporation

Steven M. Eyl insider trading

Heska Corporation

Mr. Steven M. Eyl has made 8 insider trades between 2015-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 24,922 units of HSKA stock on 9 Aug 2018. As of 7 Mar 2022 he still owns at least 10,048 units of HSKA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,562 N/A N/A
Option
Performance Shares 1,562 N/A N/A
Option
Common Stock 1,563 N/A N/A
Option
Performance Shares 1,563 N/A N/A
Option
Performance Shares 1,563 N/A N/A
Option
Common Stock 1,563 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 7,378 $98 $723,044
Option
Non-Qualified Stock Option (right to buy) 7,378 N/A N/A
Sale
Common Stock 5,937 N/A N/A
Option
Common Stock 7,378 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 1,051 N/A N/A
Sale
Common Stock 1,051 N/A N/A
Option
Common Stock 1,051 N/A N/A
Sale
Common Stock 24,922 N/A N/A
Option
Incentive Stock Option (right to buy) 15,819 $21.75 $344,063
Option
Non-Qualified Stock Option (right to buy) 5,353 N/A N/A
Option
Common Stock 24,922 N/A N/A
Sale
Common Stock 24,922 $99.19 $2,471,963
Option
Incentive Stock Option (right to buy) 15,819 N/A N/A
Sale
Common Stock 582 N/A N/A
Option
Incentive Stock Option (right to buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 105 $30.07 $3,157
Option
Incentive Stock Option (right to buy) 2,336 $18.71 $43,714
Option
Common Stock 2,336 $18.71 $43,714
Option
Common Stock 3,645 $30.27 $110,338
Sale
Common Stock 3,645 $30.27 $110,338
Option
Incentive Stock Option (right to buy) 3,645 $30.27 $110,338

Heska key executives

Heska Corporation executives and other stock owners filed with the SEC:

  • Dr. Nancy Wisnewski (62) Executive Vice President & Chief Operating Officer
  • Mr. Kevin S. Wilson (53) Chief Executive Officer, Pres & Director
  • Mr. Steven M. Eyl (59) Executive Vice President, Chief Commercial Officer & Pres of scil animal care company
  • Ms. Catherine I. Grassman CPA (49) Executive Vice President & Chief Financial Officer